STOCK TITAN

StableX Technologies (SBLX) Financials

SBLX NASDAQ

Ticker history: SBLX became FABC (Fabric.AI, Inc.) on . Earlier news and filings retain their original names and dates. View SBLX history.

Trailing 12 months to March 31, 2026
Net Income -$24.3M -992.5% YoY
EPS (Diluted) -$32.24 FY2025 annual
Operating Cash Flow -$4.2M n/m YoY
Gross Profit -$956K FY2025 annual
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 15, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SBLX SEC filings page.

This page shows StableX Technologies, Inc. (SBLX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SBLX FY2025

Reported earnings are disconnected from operations: the company posted net income while operating losses and cash outflows persisted.

FY2025 reported net income was $21.1M, yet operating cash flow was -$7.7M. FY2024 also paired positive net income of $1.8M with operating cash flow of -$13.3M, indicating that bottom-line gains have not been converting into operating cash.

The balance sheet contracted sharply: total assets fell from $21.7M in FY2024 to $11.4M in FY2025, while total liabilities fell from $17.1M to $7.7M. Because liabilities declined alongside assets, the change looks more like balance-sheet shrinkage than expansion funded by new resources.

Liabilities represented 67.5% of assets in FY2025, down from 78.5%, while the current ratio improved from 5.1x to 5.6x. Even so, the operating engine remained loss-making: operating income was a loss of $10.5M despite reported net income of $21.1M, separating reported profitability from core operating performance.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for StableX Technologies, Inc., because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
3/6

StableX Technologies, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, StableX Technologies, Inc. used $0.36 of operating cash (-$7.7M OCF vs $21.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage At Risk
N/A

StableX Technologies, Inc. reported an operating loss of $10.5M against $127K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$2.4M
YoY-385.7%
QoQn/m
5Y CAGRn/m

StableX Technologies, Inc. reported a net loss of $2.4M in Q1 2026. This represents a decrease of 385.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$2.42

StableX Technologies, Inc. earned -$2.42 per diluted share (EPS) in Q1 2026.

Revenue

Not reported for Q1 2026.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt
$3.3M
YoY-74.5%
QoQ-34.5%
5Y CAGR-48.7%

StableX Technologies, Inc. held $3.3M in cash as of Q1 2026; no long-term debt figure is on record for that period.

Shares Outstanding
1M
QoQ0.0%

StableX Technologies, Inc. had 1M shares outstanding in Q1 2026. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Return on Equity
-204.6%
YoY-232.7pp
QoQ-68.9pp

StableX Technologies, Inc.'s quarterly ROE was -204.6% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is down 232.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 68.9 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Net Margin

Not reported for Q1 2026.

Capital Allocation

R&D Spending
$125K
YoY-59.4%
QoQ-68.3%
5Y CAGR-42.2%

StableX Technologies, Inc. invested $125K in research and development in Q1 2026. This represents a decrease of 59.4% from the same quarter a year earlier. Against the prior quarter it is down 68.3%.

Share Buybacks

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

SBLX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SBLX quarterly income statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
RevenueN/AN/AN/AN/AN/AN/A$5K-93.9%N/A
Cost of RevenueN/AN/A$717K+150.7%$239K-77.8%N/A$4.1M-5.6%$286K+23.4%$1.1M+223.7%
Gross ProfitN/AN/A-$717Kn/m-$239Kn/mN/A-$4.1Mn/m-$281Kn/m-$1.1Mn/m
R&D Expenses$125K-59.4%$394K+312.5%$344K+2225.1%$350K-43.8%$308K-59.5%$95K-93.8%$15K-98.9%$623K-74.1%
SG&A Expenses$1.6M-5.4%$2.8M$2.5M+74.9%$1.2M-39.3%$1.7M-45.6%N/A$1.4M-67.6%$2.0M-39.1%
Operating Income-$1.7Mn/m-$3.2Mn/m-$3.5Mn/m-$1.8Mn/m-$2.0Mn/m-$8.3Mn/m-$1.9Mn/m-$4.0Mn/m
EBITDAN/AN/AN/AN/A-$2.0Mn/mN/A-$1.6Mn/m-$3.6Mn/m
Interest Expense$10K-61.9%N/A$62K-30.4%$8K-94.3%$26K-82.9%N/A$89K+150.5%$141K+19.9%
Net Income-$2.4M-385.7%-$5.0Mn/m-$2.8M-601.0%-$14.1M-304.5%$845Kn/m-$5.6M-109.6%$551Kn/m$6.9Mn/m
EPS (Basic)-$2.42N/A-$3.84-$29.87-$0.20n/mN/A-$3.96n/m$12.45
EPS (Diluted)-$2.42N/A-$3.84-$29.87-$0.20n/mN/A-$3.96n/m$2.17
Diluted Shares (Avg)1MN/A946,139554,9899M+73.3%N/A428,952-91.0%1M

Not reported in any period shown, so not listed: Income Tax.

SBLX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SBLX quarterly balance sheet
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Total Assets$9.5M-41.3%$11.4M-47.5%$15.7M-56.3%$9.2M-79.6%$16.2M-66.3%$21.7M-58.9%$35.9M-39.9%$45.0M+3.5%
Current Assets$8.0M-49.4%$9.2M-56.7%$13.8M-58.5%$8.8M-79.0%$15.7M-64.5%$21.3M-56.6%$33.4M-39.9%$42.0M+6.4%
Cash & Equivalents$3.3M-74.5%$5.0M-68.9%$7.3M+166.0%$5.1M-63.6%$12.8M+134.8%$16.0M-52.0%$2.7M-17.0%$14.1M+3.8%
InventoryN/AN/AN/AN/AN/AN/A$3.2M-26.2%$3.3M+8.7%
Accounts ReceivableN/AN/AN/AN/AN/AN/AN/A$129K+24.1%
Total Liabilities$8.3M-36.8%$7.7M-54.9%$7.4M-69.8%$22.3M-30.7%$13.1M-67.8%$17.1M-56.0%$24.5M-0.4%$32.2M+1237.0%
Current Liabilities$1.6M-77.9%$1.6M-60.5%$1.9M-62.4%$7.6M+16.1%$7.1M+77.4%$4.2M-3.4%$5.1M+153.1%$6.5M+262.7%
Non-Current Liabilities$6.7M+12.2%$6.1M-53.0%$5.5M-71.8%$14.7M-42.6%$6.0M-83.7%$12.9M-62.5%$19.4M-14.1%$25.6M+4160.4%
Total Equity$1.2M-60.7%$3.7M-20.8%$8.3M-27.3%-$13.1M-202.1%$3.0M-57.1%$4.7M-66.9%$11.5M-58.0%$12.8M-68.8%
Retained Earnings-$140.6Mn/m-$138.2Mn/m-$133.1Mn/m-$130.4Mn/m-$116.2Mn/m-$117.1Mn/m-$111.5Mn/m-$112.1Mn/m

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill, Long-Term Debt.

SBLX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SBLX quarterly cash flow statement
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Operating Cash Flow-$1.1Mn/m-$1.6Mn/m$1.2Mn/m-$2.6Mn/m-$1.5Mn/m-$3.0Mn/m-$3.5Mn/m-$2.2Mn/m
Depreciation & AmortizationN/AN/AN/AN/A$7K-98.0%N/A$348K+7.3%$349K+37.1%
Stock-Based Compensation$611KN/AN/A$69Kn/mN/AN/A$81-100.0%-$4K-101.8%
Capital ExpendituresN/AN/AN/AN/AN/A$36K-45.3%N/AN/A
Free Cash FlowN/AN/AN/AN/AN/A-$3.0Mn/mN/AN/A
Investing Cash Flow-$219K-112.5%-$540K-104.4%-$3.3M-148.5%-$725K-163.3%$1.7Mn/m$12.2M-65.2%$6.9Mn/m$1.1Mn/m
Financing Cash Flow-$404Kn/m-$88Kn/m$7.4Mn/m-$4.3M-$3.5M-$5.8Mn/m-$4.7MN/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

SBLX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SBLX quarterly financial ratios
MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Gross MarginN/AN/AN/AN/AN/AN/A-5171.4%N/A
Operating MarginN/AN/AN/AN/AN/AN/A-35495.9%N/A
Net MarginN/AN/AN/AN/AN/AN/A10146.6%N/A
Return on Equity-204.6%-232.7pp-135.6%-16.4pp-33.1%-37.9ppN/A28.1%+80.0pp-119.2%-531.1pp4.8%+50.9pp53.9%+68.5pp
Return on Assets-25.4%-30.7pp-44.1%-18.4pp-17.5%-19.1pp-153.8%-169.2pp5.2%+12.8pp-25.7%-135.8pp1.5%+22.6pp15.4%+29.2pp
Current Ratio5.05+2.8x5.60+0.5x7.23+0.7x1.16-5.3x2.20-8.8x5.11-6.3x6.55-21.0x6.42-15.5x
Liabilities-to-Equity7.04+2.7x2.07-1.6x0.89-1.2xN/A4.37-1.5x3.64+0.9x2.14+1.2x2.51+2.4x
Asset TurnoverN/AN/AN/AN/AN/AN/A0.000.0xN/A

Not reported in any period shown, so not listed: Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
StableX Technologies, Inc. SBLX FY2025 N/A $21.1M N/A N/A —
Workhorse Group, Inc WKHS FY2025 $21.2M -$64.1M N/A $34.2M 49/100
Cenntro Inc. CENN FY2025 $18.1M -$73.0M N/A $2.5M 50/100
Fly-E Group, Inc. FLYE FY2026 $19.1M -$9.3M -48.6% $3.7M 28/100
Digital Currency X Technology Inc. DCX FY2025 N/A -$30.1M N/A $2.5M —
Faraday Future Intelligent Electric Inc. FFAI FY2025 $536K -$390.7M N/A $2.0M —

Frequently Asked Questions

No, StableX Technologies, Inc. (SBLX) reported a net loss of $24.3M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net income of $21.1M.

StableX Technologies, Inc. (SBLX) reported diluted earnings per share of -$32.24 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

StableX Technologies, Inc. (SBLX) had EBITDA of -$10.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

StableX Technologies, Inc. (SBLX) has a return on equity of 568.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

StableX Technologies, Inc. (SBLX) recorded an outflow of $7.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

StableX Technologies, Inc. (SBLX) had $11.4M in total assets as of fiscal year 2025, including both current and long-term assets.

StableX Technologies, Inc. (SBLX) invested $1.4M in research and development during fiscal year 2025.

StableX Technologies, Inc. (SBLX) had 1M shares outstanding as of fiscal year 2025.

StableX Technologies, Inc. (SBLX) had a current ratio of 5.60 as of fiscal year 2025, which is generally considered healthy.

StableX Technologies, Inc. (SBLX) had a liabilities-to-equity ratio of 2.07 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

StableX Technologies, Inc. (SBLX) had a return on assets of 184.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

StableX Technologies, Inc. (SBLX) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, StableX Technologies, Inc. (SBLX) used $0.36 of operating cash (-$7.7M OCF vs $21.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

StableX Technologies, Inc. (SBLX) reported an operating loss of $10.5M against $127K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top